Time to First Progression, but Not Β2-Microglobulin, Predicts Outcome in Myeloma Patients Who Received Thalidomide as Salvage Therapy.
暂无分享,去创建一个
M. Boccadoro | S. Bringhen | F. Cavallo | A. Palumbo | B. Bruno | T. Caravita | P. Falco | C. Rus | M. T. Ambrosini | I. Avonto | G. Gallone